Withings BodyScan 2 arrives in Europe as US launch nears

Withings BodyScan 2 is now available to buy in Europe, taking the company’s new flagship smart scale out of early access and into a wider public launch. The US release is close too, with Withings telling users that the wait ends next week.

The launch follows the BodyScan 2 Insider Program from May. This gave 500 European users early access to final production hardware.

Withings leans hard into longevity

Withings is calling BodyScan 2 its first science-backed longevity station. That is a big label, but the idea is simple enough. The scale tries to turn a daily weigh-in into a broader cardiometabolic check.

It measures more than 60 biomarkers over time and pulls key signals into Longevity Intelligence inside the Withings app. That is meant to act as a health cockpit, showing how your body is trending rather than just displaying isolated readings.

The main features include 6-zone body composition, metabolic assessment, complete heart health and Longevity Intelligence. It still looks like a smart scale, but Withings clearly wants it to sit closer to a home health monitor than a weight tracker.

Body composition is the easy sell

The 6-zone body composition feature will probably be the most useful part for many buyers. Instead of giving one whole-body estimate, BodyScan 2 breaks fat and muscle readings down across different body zones.

That should make progress easier to understand. Weight alone does not say much when someone is building muscle, losing fat or trying to avoid lean mass loss. A more detailed breakdown gives users something more practical to track.

As always with home body composition scales, the exact number should not be treated as lab-grade truth. The value is in regular readings under similar conditions and watching the trend over time.

Metabolic tracking is where it gets more ambitious

The metabolic side is more interesting, although part of it is not ready yet. Withings says BodyScan 2 can track visceral fat, calorie balance and Glucose Resilience, but Glucose Resilience is marked as coming soon.

Now make no mistake, BodyScan 2 is not a continuous glucose monitor. And it is not directly measuring blood sugar. This looks more like a broader metabolic score built from the data Withings can collect or model through its app.

BodyScan 2 also brings in several cardiovascular features. Withings lists AFib detection, vascular age, blood oxygen, cardiac efficiency and hypertension notifications.

The scale is not cheap and some of the more interesting features are tied to Withings+. Heart Age is one example. It turns cardiac timing and efficiency data into an age-style score, which may be easier for users to understand than raw numbers.

Europe first, US next

BodyScan 2 is available now in Europe through the Withings website. In the UK it is priced at £450.

The US launch should follow next week. The company also says the white version is not available yet, but should arrive before the end of summer.